ClinicalTrials.govpublic full text
Study to Evaluate the Effects of Sorafenib if Combined With Chemotherapy (FOLFOX6 or FOLFIRI) in the Second-Line Treatment of Colorectal Cancer
colorectal neoplasms, second-line therapy of metastatic colorectal cancer, sorafenib, palliative therapy, after progression of firstline therapy with an oxaliplatin- or irinotecan based fluoropyrimidine containing regimen ± bevacizumab, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804796
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.